Focus on Patients

  1. Meaningful Industry Change Means Balancing Tech And Human Touch 5/6/2024

    Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.

  2. Yes, Women's Exclusion In Clinical Trials Is Still A Problem 4/22/2024

    Despite the progress made in including women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek explains why the fight for inclusion isn't over.

  3. AI Technologies Drive Drug Development And Enhance Patient Experience In Neurology & Rare Diseases 3/21/2024

    Digital healthcare and AI technologies play a crucial role in exploring and treating a range of rare diseases as we welcome a new era of personalized care and potentially better patient outcomes.

  4. Latest CISCRP Patient Survey Reveals Diversity Gaps, Yields 5 Tips For Improvement 3/20/2024

    Results from the latest CISCRP “Perceptions & Insights” study reveal five opportunities to improve clinical trial recruitment and participation, especially among ethnic and racial minority groups.

  5. What's Needed To Keep Tinnitus Research From Going Quiet 3/18/2024

    Finding effective treatments for tinnitus has often been circuitous and frustrating for many patients. Tinnitus expert Marc Fagelson, Ph.D., explores the current treatment landscape and what can be done to improve outcomes for patients.

  6. Is Ignoring Gender Non-Conformity Research Holding Us Back? 3/4/2024

    Including individuals across the gender spectrum in clinical trials isn't just the right thing to do, it's also strategic move with benefits for science, society, and business.

  7. Tokenism In Clinical Trials For Rare Disease Patients 2/29/2024

    While recent efforts promote diversity in clinical trials, the lack of enforcement and tokenistic approaches risk leaving people of color behind. This article delves into the urgency of addressing this crisis and building genuine inclusivity for a healthier future for all.

  8. Post-Pandemic Planning: Using Direct-To-Patient Deliveries For Supply Chain Management 2/23/2024

    UCB Vice President – Head of Global Clinical Science and Operations Tero Laulajainen gets us up to speed on direct-to-patient (DTP) trials and how UCB is leveraging it today.

  9. 4 Things I Learned At SCOPE 2024 2/21/2024

    The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.

  10. Addressing Underrepresentation In Cancer Trials: A Q&A With Stand Up To Cancer & Triage Cancer 2/13/2024

    Clinical Leader heard from both sides of the collaboration — SU2C researcher Dr. Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq. — to explore each’s efforts to together bring health equity to those diagnosed with cancer.